Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7,87 HKD | +4,79% | +20,71% | +3,01% |
Vakgebied
Aantal werknemers: 198
Verkoop per activiteit
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biopharmaceutical Research and Development
100,0
%
| 660 | 100,0 % | 702 | 100,0 % | +6,34% |
Verkoop per regio
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 660 | 100,0 % | 702 | 100,0 % | +6,34% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Zhao Long Gong
CEO | Chief Executive Officer | 60 | 01-01-14 |
Jing Zhang
DFI | Director of Finance/CFO | 50 | 28-08-20 |
Zhi Qiang Xue
CTO | Chief Tech/Sci/R&D Officer | - | - |
Ming Zhu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Shen Xiao
CTO | Chief Tech/Sci/R&D Officer | - | 01-03-21 |
Fang Xia
IRO | Public Communications Contact | 43 | 01-09-20 |
Yue He
PRN | Corporate Officer/Principal | 46 | 01-08-19 |
Yihui Lin
PRN | Corporate Officer/Principal | 44 | 30-01-18 |
Ching Yi Li
SEC | Corporate Secretary | - | 25-06-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tat Pang Lin
BRD | Director/Board Member | 67 | 01-12-22 |
Xin Guang Liu
BRD | Director/Board Member | 63 | 25-06-21 |
Zhao Long Gong
CEO | Chief Executive Officer | 60 | 01-01-14 |
Jin Li
BRD | Director/Board Member | 59 | 25-06-21 |
Pai Zhu
BRD | Director/Board Member | 31 | 23-06-21 |
Feng Zhou
BRD | Director/Board Member | 42 | 09-10-19 |
Yawen Chen
BRD | Director/Board Member | 32 | 12-07-22 |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,01% | 218 mln. | |
+9,42% | 115 mld. | |
+11,84% | 106 mld. | |
-1,05% | 21,96 mld. | |
-14,15% | 21,87 mld. | |
-5,29% | 19,21 mld. | |
-4,16% | 18,08 mld. | |
-38,29% | 17,71 mld. | |
+7,99% | 14,32 mld. | |
+36,24% | 12,42 mld. |
- Beurs
- Aandelen
- Koers 1244
- Onderneming 3D Medicines Inc.